Back to list

Auron Therapeutics

Biotechnology company with a recent SEC Form D offering.
Biotech 📍 Wellesley, MASSACHUSETTS
Current Valuation
Private
PRIVATE
Biotechnology company headquartered in Wellesley, MASSACHUSETTS. Filed SEC Form D on 20260813 for a $7.1M Regulation D offering.

Company Profile

HQ
Wellesley, MASSACHUSETTS
Total Raised
$7.12M
Growth
Filed SEC Form D on 20260813 for $7.1M Regulation D offering
Last Round
Form D filing — $7.12M (20260813)
IPO Status
private

Fundraising Status

Form D filing · $7.12M
privateTotal raised $7.12M

Latest Funding Round

RoundAmountDateLead InvestorPost-Money
Form D filing$7.12M20260813

Talent Signal

Hiring data for Auron Therapeutics has not been collected yet — the monthly talent sweep hasn't reached this company. Check back soon.
BiotechForm DRecently Funded
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of recent date. Refreshed quarterly.